EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.1.1.146 | 11beta-hydroxysteroid dehydrogenase |
fetus |
- |
762011 |
1.1.1.149 | 20alpha-hydroxysteroid dehydrogenase |
fetus |
- |
699835 |
1.1.1.189 | prostaglandin-E2 9-reductase |
fetus |
- |
670733 |
1.1.1.213 | 3alpha-hydroxysteroid 3-dehydrogenase (Re-specific) |
fetus |
- |
687639 |
1.1.1.315 | 11-cis-retinol dehydrogenase |
fetus |
fetal brain (5% mRNA expression of Rdh5 compared to adult liver), fetal heart (6% mRNA expression of Rdh5 compared to adultliver), fetal kidney (17% mRNA expression of Rdh5 compared to adult liver), fetal liver (20% mRNA expression of Rdh5 compared to adult liver), fetal spleen (5% mRNA expression of Rdh5 compared to adult liver), fetal thymus (7% mRNA expression of Rdh5 compared to adult liver), fetal lung (14% mRNA expression of Rdh5 compared to liver) |
690797 |
1.14.11.2 | procollagen-proline 4-dioxygenase |
fetus |
- |
439148, 439198 |
1.14.11.2 | procollagen-proline 4-dioxygenase |
fetus |
foot |
439243 |
1.14.11.2 | procollagen-proline 4-dioxygenase |
fetus |
skin |
439148 |
1.14.11.2 | procollagen-proline 4-dioxygenase |
fetus |
skin, mixture of fetal tissues |
439211 |
1.14.11.65 | [histone H3]-dimethyl-L-lysine9 demethylase |
fetus |
- |
752641 |
1.14.19.3 | acyl-CoA 6-desaturase |
fetus |
- |
438418 |
1.3.1.21 | 7-dehydrocholesterol reductase |
fetus |
with holoprosencephaly at gestation age of 21 to 33 weeks |
654450 |
1.3.8.8 | long-chain acyl-CoA dehydrogenase |
fetus |
- |
671771 |
1.5.1.15 | methylenetetrahydrofolate dehydrogenase (NAD+) |
fetus |
- |
392077, 392087 |
1.5.1.30 | flavin reductase (NADPH) |
fetus |
the enzyme is predominant during fetal development but sometimes detectable through adulthood |
763055 |
2.1.1.45 | thymidylate synthase |
fetus |
- |
485374, 485395, 485404 |
2.1.1.5 | betaine-homocysteine S-methyltransferase |
fetus |
low BHMT activity is detected in the G30 fetus, and slightly increased levels of activity are observed in the liver from G45 and G90 fetuses |
733936 |
2.3.1.194 | acetoacetyl-CoA synthase |
fetus |
prenatal nicotine exposure leads to decreased expression and increased DNA methylation in the proximal promoter of acetoacetyl-CoA synthetase |
737280 |
2.3.1.286 | protein acetyllysine N-acetyltransferase |
fetus |
- |
738438 |
2.3.1.57 | diamine N-acetyltransferase |
fetus |
primary fetal fibroblasts |
487267 |
2.3.3.10 | hydroxymethylglutaryl-CoA synthase |
fetus |
- |
488111 |
2.4.1.50 | procollagen galactosyltransferase |
fetus |
- |
489282 |
2.4.2.31 | NAD+-protein-arginine ADP-ribosyltransferase |
fetus |
low level |
638113 |
2.6.1.13 | ornithine aminotransferase |
fetus |
- |
637132 |
2.6.1.13 | ornithine aminotransferase |
fetus |
small intestine |
637127 |
2.7.1.105 | 6-phosphofructo-2-kinase |
fetus |
isozyme variant F-PFK2 |
737973 |
2.7.1.21 | thymidine kinase |
fetus |
- |
641143 |
2.7.1.40 | pyruvate kinase |
fetus |
M2-type isozyme |
641555 |
2.7.10.1 | receptor protein-tyrosine kinase |
fetus |
expressed in definitive endoderm of the developing gut and extraembryonic endoderm of the yolk-sac from 8.5 to 14.5 days p.c. |
490545 |
2.7.10.1 | receptor protein-tyrosine kinase |
fetus |
FGFR-4 is expressed as a 3.0 kb mRNA in the adrenal, lung, kidney, liver, pancreas, intestine, striated muscle and spleen tissues of human fetuses |
490321 |
2.7.10.1 | receptor protein-tyrosine kinase |
fetus |
spleen, brain intermediate zone, and lung showing the highest levels of activity |
490396 |
2.7.11.12 | cGMP-dependent protein kinase |
fetus |
- |
721982 |
2.7.11.25 | mitogen-activated protein kinase kinase kinase |
fetus |
- |
741324 |
2.7.11.26 | tau-protein kinase |
fetus |
- |
640828, 640829 |
2.7.11.31 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase |
fetus |
- |
693845 |
2.7.4.14 | UMP/CMP kinase |
fetus |
- |
645160 |
2.7.7.1 | nicotinamide-nucleotide adenylyltransferase |
fetus |
- |
761048 |
2.7.7.18 | nicotinate-nucleotide adenylyltransferase |
fetus |
- |
761048 |
2.8.2.15 | steroid sulfotransferase |
fetus |
foetal tissue is a much richer source of enzyme than adult |
645724 |
2.8.2.17 | chondroitin 6-sulfotransferase |
fetus |
- |
645758 |
2.8.2.2 | alcohol sulfotransferase |
fetus |
- |
645782, 645783, 645790, 645797 |
2.8.2.21 | keratan sulfotransferase |
fetus |
- |
645834 |
2.8.2.4 | estrone sulfotransferase |
fetus |
- |
645892 |
2.8.2.8 | [heparan sulfate]-glucosamine N-sulfotransferase |
fetus |
brain |
645941 |
3.1.1.7 | acetylcholinesterase |
fetus |
fetal cerebral tissue |
677724 |
3.1.3.47 | [hydroxymethylglutaryl-CoA reductase (NADPH)]-phosphatase |
fetus |
- |
94961 |
3.1.3.53 | [myosin-light-chain] phosphatase |
fetus |
normal and pulmonary hypertensive fetal sheep, pulmonary artery, aorta and vena cava |
646359 |
3.1.4.53 | 3',5'-cyclic-AMP phosphodiesterase |
fetus |
- |
710817 |
3.2.1.51 | alpha-L-fucosidase |
fetus |
- |
208715 |
3.2.1.52 | beta-N-acetylhexosaminidase |
fetus |
fetal membrane |
393726 |
3.2.2.29 | thymine-DNA glycosylase |
fetus |
TDG transcripts are uniformly and ubiquitously expressed from 7.5 days post-coitum, but are then markedly enriched in specific tissues of the developing fetus. At 14.5 gestational days, TDG is strongly expressed in the developing nervous system, thymus, lung, liver, kidney and intestine. At later stages, high levels of expression were detected in the thymus, brain, nasal epithelium and within proliferating regions of the intestine, skin, kidney, teeth and bone |
694487 |
3.4.21.119 | kallikrein 13 |
fetus |
- |
679276 |
3.4.21.69 | Protein C (activated) |
fetus |
fetal neural stem and progenitor cells |
753070 |
3.4.21.69 | Protein C (activated) |
fetus |
fetal neural stem/progenitor cells |
754858 |
3.4.22.38 | cathepsin K |
fetus |
- |
708450 |
3.4.22.61 | caspase-8 |
fetus |
- |
710108 |
3.4.24.11 | neprilysin |
fetus |
- |
81605 |
3.4.24.23 | matrilysin |
fetus |
expression and activity of MMP-7 in fetal membranes during premature rupture of membranes, immunohistochemic analysis, overview |
684052 |
3.4.24.35 | gelatinase B |
fetus |
- |
683881 |
3.4.24.7 | interstitial collagenase |
fetus |
- |
710259 |
3.5.1.15 | aspartoacylase |
fetus |
- |
719532 |
4.1.1.17 | ornithine decarboxylase |
fetus |
- |
-, 748048 |
4.1.1.19 | arginine decarboxylase |
fetus |
- |
748048 |
4.1.1.22 | histidine decarboxylase |
fetus |
- |
4142 |
5.2.1.8 | peptidylprolyl isomerase |
fetus |
foetal brain |
660614 |
6.2.1.3 | long-chain-fatty-acid-CoA ligase |
fetus |
isoform ACSL3 |
746549 |
7.6.2.1 | P-type phospholipid transporter |
fetus |
- |
720521 |